Navigation Links
Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009
Date:2/17/2009

Net cash provided by (used in) financing activities 1,410,770 (5,561,848) EFFECTS OF EXCHANGE RATE CHANGE IN CASH 369,646 513,427 INCREASE (DECREASE) IN CASH 28,184,062 (4,103,427) CASH, beginning of period 48,195,798 17,737,208 CASH, end of period $76,379,860 $13,633,781 GENESIS PHARMACEUTICALS ENTERPRISES, INC. AND SUBSIDIARIES RECONCILIATION OF NON-GAAP NET INCOME For Three Months Ended For Six Months Ended December 31 December 31 December 31 December 31 2008 2007 2008 2007 Net Income 5,399,186 5,153,463 8,532,670 8,388,455 Realized loss (income) on trading securities, net 418,134 (8,993) 1,459,656 (8,993) Amortization of debt discount and debt issuance costs related to convertible debetures 1,153,760 272,679 1,986,385 272,679 Adjusted Net Income 6,971,080 5,417,149 11,978,711 8,652,141 Adjusted Earnings Per Weighted Average Number of Shares $0.71 $0.56 $1.23 $1.46 Weighted Average Number of Shares 9,771,883 9,641,742 9,770,615 5,907,192 For more information, please contact: Genesis Pharmaceuticals Enterprises, Inc. Ms. Elsa Sung, CFO Tel: +1-954-727-8435 Email: elsasung@jiangbo.com Web: http://www.genesispharmaceuticals.com CCG Investor Relations, Inc. Mr. Crocker Coulson, President Tel: +1-646-213-1915 Email: '/>"/>
SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
2. Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area
3. AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
4. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
5. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
6. OmegaGenesis Announces Angiogenesis Application Collaboration
7. Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
8. Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
9. Cardiogenesis Reports Third Quarter 2008 Results
10. ThermoGenesis Presentation at Rodman & Renshaw Conference
11. Genesis Pharmaceuticals Launches New Corporate Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Audacity, a leading California-based health and science ... Huntsworth Health Group, is proud to announce the addition ... role, Gonzales will serve as Senior Vice President of ... welcome a talent of Jamie’s caliber to the Audacity ... is a proven healthcare innovation leader and brand management ...
(Date:12/17/2014)... SILVER SPRING, Md. , Dec. 17, 2014 /PRNewswire/ ... today two senior executive promotions as well as changes ... Senior Executive Promotions United ... Ph.D. to President and Co-Chief Executive Officer and ... Chief Operating Officer.  In connection with these promotions, Dr. ...
(Date:12/17/2014)... Dec. 17, 2014 Tigercat Pharma, Inc. ... study evaluating the investigational oral NK-1 receptor antagonist ... severe, chronic itch who are unresponsive or inadequately ... topical steroids and antihistamines. The ... Analog Scale (VAS) itch score from baseline, comparing ...
(Date:12/15/2014)... December 15, 2014 METTLER TOLEDO ... PVM tool, ParticleView V19 with PVM technology ... probe-based particle vision and measurement tool continuously captures ... conditions. ParticleView V19 then automatically prepares a report ... particle size and concentration changes. This compelling blend ...
Breaking Biology Technology:Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ... been granted its 32nd U.S. Patent, # 7,582,289, entitled ... patent claims cover methods of using modified parapoxvirus orf ... expands our intellectual property portfolio regarding oncolytic viruses, in ...
... WILMINGTON, Delaware, September 1 ... (2009-2014), published,by MarketsandMarkets ( http://www.marketsandmarkets.com ), the total global,biomaterials ... 2014, growing,at a CAGR of 15.0% from 2009 to ... 42% of the total revenues. The biomaterials market today ...
... thorough, system-level assessment of the diversity of an ... Microbes belonging to that genus frequently participate in ... in the environment. The team of researchers ... University and the Pacific Northwest National Laboratory analyzed ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Announces Issuance of 32nd U.S. Patent 2Global Biomaterials Market Worth US$58.1 Billion by 2014 2Global Biomaterials Market Worth US$58.1 Billion by 2014 3Hidden diversity in key environmental cleanup microbes found by systems biology assessment 2Hidden diversity in key environmental cleanup microbes found by systems biology assessment 3
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint ... http://photos.prnewswire.com/prnh/20130307/600769 ... than the iPhone 5S, Samsung introduces for the ... The Galaxy S5 home button presents ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... CORVALLIS, Ore. -- Zoologists at Oregon State University have ... fungal pathogen which is devastating amphibian populations around the world. ... provide a desperately needed tool for biological control of this ... efficacy in a natural setting. The fungus, B. ...
... PHOENIX, Ariz. Aug. 26, 2011 Waters Corporation ... Translational Genomics Research Institute (TGen) as a Waters Center ... Petritis, Head of TGen,s Center for Proteomics, and his ... and biomarker discovery and verification. In a ceremony ...
... obesity epidemic has been escalating for decades, yet long-term ... to a new paper from international public health experts ... journal The Lancet . Noting that many countries ... the authors call on governments around the world to ...
Cached Biology News:Possible biological control discovered for pathogen devastating amphibians 2TGen's Center for Proteomics selected as Waters Center of Innovation 2Government-led efforts targeting eating habits of children needed to curb worldwide obesity epidemic 2Government-led efforts targeting eating habits of children needed to curb worldwide obesity epidemic 3
Request Info...
... automated perfusion system. For real-time or ... biophysics, electrochemistry, or general liquid-handling research ... millisecond accuracy Run experiments automatically ... accuracy and flexibility Turnkey perfusion ...
Recombinant Human PTP1B (aa 2-321), CF...
... DuoSet ELISA Development kit contains the basic ... ELISAs to measure natural and recombinant rat ... serum. Each kit contains sufficient materials to ... provided that the following conditions are met: ...
Biology Products: